Please login to the form below

Not currently logged in
Email:
Password:

Glythera

This page shows the latest Glythera news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from Cancer

  • Glythera appoints Dr Mike Owen Glythera appoints Dr Mike Owen

    He joins as a non-executive director. Antibody drug conjugate development company, Glythera has appointed Dr Mike Owen as its non-executive director. ... Dr Sam Williams, chairman of Glythera, said: “We are delighted to welcome Mike to the board at

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...